ENTITY

Zhejiang Hisun Pharmaceutical Co, Ltd. (600267 CH)

26
Analysis
Health CareChina
Zhejiang Hisun Pharmaceutical Co. Ltd. develops and manufactures pharmaceutical products. The Company's products include anti-tumor, anti-parasite, cardiovascular, and anti-infection drugs.
more
Refresh
bearishPfizer Inc
09 Nov 2022 09:02

Pfizer Inc (PFE.US) - What if Pfizer Loses the China Market in the Future?

Pfizer’s China business faces challenges due to VBP/NRDL negotiation and potential further deterioration of Sino-US relations. Together with...

Logo
155 Views
Share
08 Jun 2022 09:19

Geopolitical Conflicts and War: The Impact on China API Industry

Energy/food crisis due to war will increase API cost, creating opportunity for China API. For IPEF/Blinken’s speech, politics is always a tool to...

Logo
229 Views
Share
15 Feb 2022 09:00

Huadong Medicine Co Ltd (000963.CH) - The Medical Cosmetology Business Is the Key Breakthrough Point

We analyzed the logic of performance decline in terms of Huadong's core business.But the entry of medical cosmetology equipment field is a wise...

Logo
209 Views
Share
21 Oct 2021 09:05

Pre-IPO Beijing Mabworks Biotech - MIL62 Alone Cannot Save the Situation

This article mainly analyzed Mabworks Biotech in terms of the important clinical-stage drug candidates (MIL62, MIL93, MBS301, MIL97, MIL95, MIL86,...

Logo
252 Views
Share
bearish3SBio Inc
29 Jun 2021 09:09

3SBio Inc (1530.HK) - The Concerns and the Outlook

This insight mainly analyzed the potential reasons behind the decline in 3SBio Group's share price, the important products, the pipeline, the...

Logo
225 Views
Share
x